Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)
$3.4100
-2.7600 ( -23.71% ) 7.4M
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.
Market Data
Open
$3.4100
Previous close
$6.1700
Volume
7.4M
Market cap
$218.44M
Day range
$3.1300 - $6.2500
52 week range
$2.2800 - $19.0500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Aug 13, 2024 |
10-q | Quarterly Reports | 80 | Aug 13, 2024 |
8-k/a | 8K-related | 13 | Aug 12, 2024 |
8-k | 8K-related | 13 | Aug 12, 2024 |
4 | Insider transactions | 1 | Jul 19, 2024 |
4 | Insider transactions | 1 | Jun 24, 2024 |
4 | Insider transactions | 1 | Jun 24, 2024 |
4 | Insider transactions | 1 | Jun 24, 2024 |
4 | Insider transactions | 1 | Jun 24, 2024 |
4 | Insider transactions | 1 | Jun 24, 2024 |